270 related articles for article (PubMed ID: 29768275)
1. Predictive Factors for the Long-Term Deterioration of Pulmonary Function in Interstitial Lung Disease Associated with Anti-Aminoacyl-tRNA Synthetase Antibodies.
Yamakawa H; Hagiwara E; Kitamura H; Iwasawa T; Otoshi R; Aiko N; Katano T; Shintani R; Ikeda S; Okuda R; Sekine A; Baba T; Iso S; Kuwano K; Sato S; Ogura T
Respiration; 2018; 96(3):210-221. PubMed ID: 29768275
[TBL] [Abstract][Full Text] [Related]
2. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anti-aminoacyl-tRNA synthetase antibody-related and idiopathic non-specific interstitial pneumonia.
Shioya S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Senoo T; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Med; 2019 Jun; 152():44-50. PubMed ID: 31128609
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies.
Koreeda Y; Higashimoto I; Yamamoto M; Takahashi M; Kaji K; Fujimoto M; Kuwana M; Fukuda Y
Intern Med; 2010; 49(5):361-9. PubMed ID: 20190466
[TBL] [Abstract][Full Text] [Related]
5. Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease.
Aiko N; Yamakawa H; Iwasawa T; Takemura T; Okudela K; Kitamura H; Hagiwara E; Ikeda S; Baba T; Iso S; Yamaguchi Y; Kondo Y; Kurabayashi T; Ohashi K; Sato S; Ogura T
Respir Investig; 2020 May; 58(3):196-203. PubMed ID: 32094078
[TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?
Lega JC; Cottin V; Fabien N; Thivolet-Béjui F; Cordier JF
J Rheumatol; 2010 May; 37(5):1000-9. PubMed ID: 20231208
[TBL] [Abstract][Full Text] [Related]
7. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T
Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
[TBL] [Abstract][Full Text] [Related]
8. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
Yoshifuji H; Fujii T; Kobayashi S; Imura Y; Fujita Y; Kawabata D; Usui T; Tanaka M; Nagai S; Umehara H; Mimori T
Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.
Yura H; Sakamoto N; Satoh M; Ishimoto H; Hanaka T; Ito C; Hasegawa T; Tanaka S; Miyamura T; Nakashima S; Hara A; Kakugawa T; Oda K; Kido T; Obase Y; Ishimatsu Y; Yatera K; Kawakami A; Mukae H
Respir Med; 2017 Nov; 132():189-194. PubMed ID: 29229096
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
[TBL] [Abstract][Full Text] [Related]
12. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience.
Chartrand S; Swigris JJ; Stanchev L; Lee JS; Brown KK; Fischer A
Respir Med; 2016 Oct; 119():150-154. PubMed ID: 27692137
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T
Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068
[TBL] [Abstract][Full Text] [Related]
16. Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.
Doyle TJ; Dhillon N; Madan R; Cabral F; Fletcher EA; Koontz DC; Aggarwal R; Osorio JC; Rosas IO; Oddis CV; Dellaripa PF
J Rheumatol; 2018 Jun; 45(6):841-850. PubMed ID: 29606668
[TBL] [Abstract][Full Text] [Related]
17. Antisynthetase syndrome: Pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetases.
Waseda Y; Johkoh T; Egashira R; Sumikawa H; Saeki K; Watanabe S; Matsunuma R; Takato H; Ichikawa Y; Hamaguchi Y; Shiraki A; Muro Y; Yasui M; Prosch H; Herold C; Kasahara K
Eur J Radiol; 2016 Aug; 85(8):1421-6. PubMed ID: 27423682
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
Hozumi H; Fujisawa T; Nakashima R; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Inui N; Nakamura Y; Mimori T; Suda T
J Rheumatol; 2019 May; 46(5):509-517. PubMed ID: 30647164
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM.
Takato H; Waseda Y; Watanabe S; Inuzuka K; Katayama N; Ichikawa Y; Yasui M; Fujimura M
Respir Med; 2013 Jan; 107(1):128-33. PubMed ID: 23137883
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy.
Sasano H; Hagiwara E; Kitamura H; Enomoto Y; Matsuo N; Baba T; Iso S; Okudela K; Iwasawa T; Sato S; Suzuki Y; Takemura T; Ogura T
BMC Pulm Med; 2016 Dec; 16(1):168. PubMed ID: 27903248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
